Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and Validation

PLoS Medicine

Volumn 10, Issue 12, 2013, Pages 1-12

  Nakahira, Kiichi ^a,b   Kyung, Sun Young ^a,c   Rogers, Angela J ^a,d,e   Gazourian, Lee ^a   Youn, Sojung ^a   Massaro, Anthony F ^a   Quintana, Carolina ^a   Osorio, Juan C ^a   Wang, Zhaoxi ^f   Zhao, Yang ^f   Lawler, Laurie A ^a   Christie, Jason D ^g   Meyer, Nuala J ^g   Causland, Finnian R Mc ^a   Waikar, Sushrut S ^a   Waxman, Aaron B ^a   Chung, Raymond T ^h   Bueno, Raphael ^a   Rosas, Ivan O ^a   Fredenburgh, Laura E ^a   Baron, Rebecca M ^a   Christiani, David C ^f,h   Hunninghake, Gary M ^a   Choi, Augustine M K ^a,b,i   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Gachon University College of Medicine   (South Korea)

^d HARVARD MEDICAL SCHOOL   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LACTIC ACID; MITOCHONDRIAL DNA; PROCALCITONIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APACHE; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; DNA ISOLATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEPSIS; SURVIVAL RATE; BLOOD; MIDDLE AGED; STATISTICS;

AGED; BIOLOGICAL MARKERS; DNA, MITOCHONDRIAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84892880111     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001577     Document Type: Article

References (43)

1. Pierrakos C, Vincent JL, (2010) Sepsis biomarkers: a review. Crit Care 14: R15.
2. Schetz MR, Van den Berghe G, (2005) Do we have reliable biochemical markers to predict the outcome of critical illness? Int J Artif Organs 28: 1197-1210.
3. Aduen J, Bernstein WK, Khastgir T, Miller J, Kerzner R, et al. (1994) The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA 272: 1678-1685.
4. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, et al. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363: 600-607.
5. Pyle A, Burn DJ, Gordon C, Swan C, Chinnery PF, et al. (2010) Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis. Intensive Care Med 36: 956-962.
6. Suliman HB, Welty-Wolf KE, Carraway MS, Schwartz DA, Hollingsworth JW, et al. (2005) Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J 19: 1531-1533.
7. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
8. Lu CH, Chang WN, Tsai NW, Chuang YC, Huang CR, et al. (2010) The value of serial plasma nuclear and mitochondrial DNA levels in adult community-acquired bacterial meningitis. QJM 103: 169-175.
9. Cossarizza A, Pinti M, Nasi M, Gibellini L, Manzini S, et al. (2011) Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. Mitochondrion 11: 750-755.
10. Sursal T, Stearns-Kurosawa DJ, Itagaki K, Oh SY, Sun S, et al. (2013) Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates. Shock 39: 55-62.
11. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, et al. (2011) Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 32: 157-164.
12. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, et al. (2011) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230.
13. Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A, (2004) Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol 75: 995-1000.
14. Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, et al. (2012) Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 185: 1225-1234.
15. Gong MN, Sai Y, Zhou W, Thompson BT, Xu LL, et al. (2003) Genotyping patients with recent blood transfusions. Epidemiology 14: 744-747.
16. Sheu CC, Gong MN, Zhai R, Chen F, Bajwa EK, et al. (2010) Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest 138: 559-567.
17. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, et al. (2002) Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62: 986-996.
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256.
19. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824.
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE, (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829.
21. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, et al. (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353: 1332-1341.
22. Hill ME, Rosenwaike I, (2001) The Social Security Administration's Death Master File: the completeness of death reporting at older ages. Soc Secur Bull 64: 45-51.
23. Bajwa EK, Khan UA, Januzzi JL, Gong MN, Thompson BT, et al. (2009) Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 136: 471-480.
24. McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, et al. (2012) The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest 122: 1574-1583.
25. Moreira VG, Prieto B, Rodriguez JS, Alvarez FV, (2010) Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem 47: 253-258.
26. Nga TV, Karkey A, Dongol S, Thuy HN, Dunstan S, et al. (2010) The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens. BMC Infect Dis 10: 125.
27. Zozaya-Hinchliffe M, Martin DH, Ferris MJ, (2008) Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol 74: 1656-1659.
28. Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, et al. (2003) Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 49: 719-726.
29. Hosmer DW, Taber S, Lemeshow S, (1991) The importance of assessing the fit of logistic regression models: a case study. Am J Public Health 81: 1630-1635.
30. Cook NR, (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928-935.
31. May Clinic Division of Biomedical Statistics and Informatics (2013) Locally written SAS macros. Available: http://www.mayo.edu/research/departments-divisions/department-health-sciences-research/division-biomedical-statistics-informatics/software/locally-written-sas-macros. Accessed 23 August13.
32. van der Vaart M, Pretorius PJ, (2008) Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci 1137: 18-26.
33. Davis BK, Wen H, Ting JP, (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707-735.
34. Henao-Mejia J, Elinav E, Strowig T, Flavell RA, (2012) Inflammasomes: far beyond inflammation. Nat Immunol 13: 321-324.
35. Makabe H, Kojika M, Takahashi G, Matsumoto N, Shibata S, et al. (2012) Interleukin-18 levels reflect the long-term prognosis of acute lung injury and acute respiratory distress syndrome. J Anesth 26: 658-663.
36. Escames G, Lopez LC, Garcia JA, Garcia-Corzo L, Ortiz F, et al. (2012) Mitochondrial DNA and inflammatory diseases. Hum Genet 131: 161-173.
37. Kung CT, Hsiao SY, Tsai TC, Su CM, Chang WN, et al. (2012) Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Transl Med 10: 130.
38. Baudouin SV, Saunders D, Tiangyou W, Elson JL, Poynter J, et al. (2005) Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 366: 2118-2121.
39. Kraft P, Wacholder S, Cornelis MC, Hu FB, Hayes RB, et al. (2009) Beyond odds ratios-communicating disease risk based on genetic profiles. Nat Rev Genet 10: 264-269.
40. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, et al. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358: 1240-1249.
41. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, et al. (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273: 117-123.
42. Pittet D, Rangel-Frausto S, Li N, Tarara D, Costigan M, et al. (1995) Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 21: 302-309.
43. Dowler WM, Shaw PD, Gottlieb D, (1963) Terminal oxidation in cell-free extracts of fungii. J Bacteriol 86: 9-17.